HGG
Showing 1 - 25 of 153
High Grade Glioma Trial in Phoenix (BDTX-1535)
Not yet recruiting
- High Grade Glioma
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Oct 2, 2023
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023
Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)
Completed
- Diffuse Intrinsic Pontine Glioma
- +6 more
-
Washington, District of Columbia
- +6 more
Jan 12, 2023
Glioma, Malignant, Surgery, Seizures Trial in Boston (Perampanel, Standard of Care)
Recruiting
- Glioma, Malignant
- +2 more
- Perampanel
- Standard of Care
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 21, 2022
High Grade Glioma Trial in Phoenix (SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS))
Recruiting
- High Grade Glioma
- SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
- MR-Guided Focused Ultrasound device (MRgFUS)
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Dec 22, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
High-Grade Glioma Trial in New York, Houston, Madison (CLR 131)
Not yet recruiting
- High-Grade Glioma
- CLR 131
-
New York, New York
- +2 more
Nov 3, 2022
High Grade Glioma Trial in Lake Success (5 Aminolevulinic Acid, CV01-delivered ultrasound)
Recruiting
- High Grade Glioma
- 5 Aminolevulinic Acid
- CV01-delivered ultrasound
-
Saint Louis, Missouri
- +2 more
Dec 21, 2022
Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients
Recruiting
- Medulloblastoma
- +7 more
- SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
- +2 more
-
Buffalo, New York
- +2 more
Jul 8, 2022
Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)
Recruiting
- Glioma
- +4 more
- 18F-Fluciclovine PET-MRI
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Dec 22, 2022
Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade
Recruiting
- Low Grade Glioma (LGG) of Brain With BRAF Aberration
- +2 more
- Dabrafenib
- +2 more
-
Phoenix, Arizona
- +12 more
Apr 7, 2022
Glioma Trial in Milan (Hypofractionated IMRT)
Completed
- Glioma
- Hypofractionated IMRT
-
Milan, ItalyIstituto Clinico Humanitas
Sep 17, 2020
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma Trial in United States (PEP-CMV, Temozolomide,
Not yet recruiting
- High Grade Glioma
- +2 more
- PEP-CMV
- +2 more
-
Aurora, Colorado
- +9 more
Jan 28, 2022
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Cancer, High-grade Glioma Trial in Amsterdam (Sunitinib, vandetanib, Erlotinib)
Unknown status
- Cancer
- High-grade Glioma
- Sunitinib
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Oct 6, 2020
Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- Fimepinostat
- Therapeutic Conventional Surgery
-
Los Angeles, California
- +18 more
Aug 16, 2022
Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)
Recruiting
- Glioblastoma
- +5 more
- Ipilimumab
- +4 more
-
Birmingham, Alabama
- +19 more
Aug 16, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Bithalamic High Grade Glioma Trial in Cincinnati (Ribociclib)
Terminated
- High Grade Glioma
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 15, 2020
From Patients With High Grade Gliomas
Recruiting
- High Grade Glioma
- Radiotherapy as per standard of care
-
Toronto, Ontario, CanadaUniversity Health Network
Jun 21, 2023
Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)
Active, not recruiting
- Glioma, Malignant
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Recurrent and Refractory Solid Tumors Trial in Canada, United States (Lenvatinib, Everolimus)
Completed
- Recurrent and Refractory Solid Tumors
-
Birmingham, Alabama
- +49 more
Jan 27, 2023
Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab
Recruiting
- Relapsed Solid Tumor
- +5 more
- cemiplimab (monotherapy)
- +3 more
-
Los Angeles, California
- +19 more
Jan 27, 2022
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Sep 26, 2022
Newly Diagnosed High Grade Glioma (HGG) Trial (Toca 511, Toca FC)
Withdrawn
- Newly Diagnosed High Grade Glioma (HGG)
- Toca 511
- Toca FC
- (no location specified)
Mar 26, 2020